326 related articles for article (PubMed ID: 3763088)
1. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
[TBL] [Abstract][Full Text] [Related]
3. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
4. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
5. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
7. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
9. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
Kleine W; Fuchs A; deGregorio G; Geyer H
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
[TBL] [Abstract][Full Text] [Related]
10. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
11. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
Soper JT; McCarty KS; Hinshaw W; Creasman WT; McCarty KS; Clarke-Pearson DL
Am J Obstet Gynecol; 1984 Oct; 150(4):342-8. PubMed ID: 6486200
[TBL] [Abstract][Full Text] [Related]
13. Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters.
Kitaoka Y; Kitawaki J; Koshiba H; Inoue S; Ishihara H; Teramoto M; Honjo H
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):183-9. PubMed ID: 15084350
[TBL] [Abstract][Full Text] [Related]
14. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
Ioffe YJ; Li AJ; Walsh CS; Karlan BY; Leuchter R; Forscher C; Cass I
Gynecol Oncol; 2009 Dec; 115(3):466-71. PubMed ID: 19767065
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Rose PG; Reale FR; Longcope C; Hunter RE
Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor content, immunohistochemically determined by monoclonal antibodies, in endometrial stromal sarcoma.
Tosi P; Sforza V; Santopietro R
Obstet Gynecol; 1989 Jan; 73(1):75-8. PubMed ID: 2462203
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor.
Segreti EM; Novotny DB; Soper JT; Mutch DG; Creasman WT; McCarty KS
Obstet Gynecol; 1989 May; 73(5 Pt 1):780-5. PubMed ID: 2704506
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid receptors in endometrial cancer.
Chambers JT
Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
20. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]